Notícias e Atividades da Beacon Biosignals

Fusão, aquisição e financiamento envolvendo Beacon Biosignals.

• Beacon Biosignals acaba de anunciar uma arrecadação de fundos de 97 milhões de dólares. (publicado em 7 de abril de 2026).

Veja o organograma con seus 19 executivos principais

Biografias mais buscadas da Beacon Biosignals

• Jacob Donoghue, Chief Executive Officer
• Caitlin Donovan, Director
• Naveen Rao, Director

Criar um alerta
para seguir os movimentos de executivos da Beacon Biosignals.

Beacon Biosignals possui 2.405 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e BioNTech (Alemanha).

Popular M&A news in Biotecnologia

• IMU Biosciences acaba de anunciar uma arrecadação de fundos de 53 milhões de dólares. (publicado em 3 de junho de 2026).
• NewLimit acaba de anunciar uma arrecadação de fundos de 435 milhões de dólares. (publicado em 3 de junho de 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (publicado em 1 de junho de 2026)..

Outros contatos sugeridos na indústria do Biotecnologia

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer da Inceptive
• Jan Van de Winkel - President and Chief Executive Officer da Genmab
• Valerie Hanote - Non-Executive Director da Eurofins

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Beacon Biosignals

• FDA Authorizes Beacon’s Dreem 3S as First Sleep Wearable with Predetermined Change Control Plan, Paving the Way for Continuous Algorithm Enhancements in Sleep Monitoring
• Beacon Launches HEADFIRST Clinical Trial to Study Sleep EEG in Pediatric Developmental Disorders, Partners with LGS Foundation
• Beacon Biosignals Announces Strategic Collaboration with Skye Bioscience to Integrate Sleep Quality and Sleep Apnea Endpoints in CBEYOND™ Phase 2 Trial of Nimacimab for Obesity
• Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions
• Beacon Biosignals and Takeda Launch Strategic Collaboration to Advance Neurobiomarkers and Endpoints for Sleep Disorders
• Beacon Biosignals Expands Sleep Analysis Capabilities with FDA Clearance of SleepStageML
• Dr. Sudhir Sivakumaran Joins Beacon Biosignals as Vice President of Translational Medicine
• Beacon Biosignals welcomes David Matthews, PhD, as Chief Business Officer
• Gate Neurosciences Announces Clinical Collaboration with Beacon Biosignals to Advance Precision EEG Biomarkers in Major Depressive Disorder
• Beacon Biosignals Elevates Brain Health Understanding at AES 2023
• View more press releases Close

Redes sociais sobre Beacon Biosignals

• Beacon Biosignals na Wikipedia, Google News e Yahoo Finance
• Beacon Biosignals na LinkedIn, X (Twitter) e YouTube